Jobs
About this opportunity:
Freenome is looking for a strategic, high-energy Director of Downstream Marketing to lead the commercial launch and market expansion of our blood-based cancer screening tests. As the first dedicated downstream leader, you will be the bridge between our breakthrough science and the healthcare providers, systems, and patients we serve.
You will own the go-to-market (GTM) execution, demand generation, and sales enablement strategies that turn our clinical evidence into a market-leading commercial brand.
This role will report to the VP, Marketing and will serve as a vital part of the Commercial Leadership Team. This is a remote or hybrid/onsite role with minimal travel requirements.
What you’ll do:
-
Commercial Launch and Campaign Execution: Execute Go-to-Market (GTM) tactics for new products and indications by delivering integrated campaigns and cross-channel collateral and sales enablement tools that translate complex early-detection science into compelling messaging for PCPs and health system stakeholders.
-
Customer acquisition and digital marketing: Develop and optimize digital marketing campaigns to drive system, HCP and patient acquisition. Oversee paid media strategy, SEO/SEM, email marketing, and conversion optimization. Use data to continuously test, refine, and scale campaigns based on performance.
-
Sales Enablement & Field Support: Partner closely with the Sales and L&D teams to develop high-impact collateral, training modules, and "objection-handling" tools that accelerate the sales cycle.
-
Brand Stewardship: Ensure a consistent, high-integrity brand voice across all physician-facing and patient-facing touchpoints.
-
Market Intelligence: Monitor the competitive landscape (Liquid Biopsy, Cologuard, etc.) to refine our positioning and maintain Freenome’s competitive edge.
-
Agency & Budget Management: Manage external creative and media agencies to deliver high-ROI campaigns while maintaining a disciplined marketing budget.
-
External Stakeholder Relations: Build relationships with industry/market thought leaders, customers, societies, internal stakeholders and provide key insights to cross-functional teams.
-
Provider Marketing & ABM: Design and execute Account-Based Marketing (ABM) strategies to engage referring physicians and healthcare professionals (HCPs). Partner with field teams to identify target segments and develop tailored content that drives referrals and builds brand trust.
Must haves:
-
Bachelor’s degree in a business, life sciences, or related field.
-
10+ years of experience in marketing, with at least 5 years specifically in downstream/commercial marketing within the molecular diagnostics, biotech, or medical device space.
-
Ability to translate dense clinical data (Sensitivity, Specificity, NPV) into a narrative that a busy physician can understand in 30 seconds.
-
Drive to thrive in the "center of the wheel," working across Sales, Medical Affairs, and Product Management to ensure everyone is aligned on the commercial mission.
-
Demonstrated data-driven decision making. You don't just "run ads"; you measure conversion rates, CAC (Customer Acquisition Cost), and physician engagement metrics to iterate constantly.
Nice to haves:
-
Experience launching a PCP-focused diagnostic test is a significant plus.
-
Familiarity with the reimbursement landscape and how it affects downstream adoption.
-
MBA or advanced degree in life sciences preferred.
Benefits and additional information:
The US target range of our base salary for new hires is $197,200 - $281,400. You will also be eligible to receive equity, cash bonuses, and a full range of medical, financial, and other benefits depending on the position offered. Please note that individual total compensation for this position will be determined at the Company’s sole discretion and may vary based on several factors, including but not limited to, location, skill level, years and depth of relevant experience, and education. We invite you to check out our career page @ freenome.com/job-openings/ for additional company information.
Freenome is proud to be an equal-opportunity employer, and we value diversity. Freenome does not discriminate on the basis of race, color, religion, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, gender identity or expression, veteran status, or any other status protected under federal, state, or local law.
*Applicants have rights under Federal Employment Laws. *
-
Family & Medical Leave Act (FMLA)
-
Equal Employment Opportunity (EEO)
-
Employee Polygraph Protection Act (EPPA)
#
Total Views
0
Apply Clicks
0
Mock Applicants
0
Scraps
0
Similar Jobs
About Freenome

Freenome
Series CFreenome is a biotechnology company that develops blood-based tests for early cancer detection using artificial intelligence and genomics.
201-500
Employees
South San Francisco
Headquarters
$2.3B
Valuation
Reviews
3.8
1 reviews
Work Life Balance
2.5
Compensation
3.0
Culture
4.0
Career
2.5
Management
2.0
60%
Recommend to a Friend
Pros
Fantastic science and mission
Great people and team
Meaningful work
Cons
Leadership struggles with decision making
Lack of concrete planning
Recent layoffs impacting teams
Salary Ranges
33 data points
Mid/L4
Principal/L7
Mid/L4 · Clinical Data Manager
1 reports
$155,250
total / year
Base
$135,000
Stock
-
Bonus
-
$155,250
$155,250
Interview Experience
46 interviews
Difficulty
3.1
/ 5
Duration
14-28 weeks
Offer Rate
38%
Experience
Positive 69%
Neutral 16%
Negative 15%
Interview Process
1
Phone Screen
2
Technical Interview
3
Hiring Manager
4
Team Fit
Common Questions
Technical skills
Past experience
Team collaboration
Problem solving
News & Buzz
Freenome Announces Expanded Artificial Intelligence and Deep Learning Initiatives Accelerated by NVIDIA, to Advance Personalized Multi-Cancer Detection - PR Newswire
Source: PR Newswire
News
·
9w ago
Peninsula company rides blank check to Wall Street after raising more than $1 billion as a startup - The Business Journals
Source: The Business Journals
News
·
14w ago
Freenome inks deals to list stock and raise $330M - MedTech Dive
Source: MedTech Dive
News
·
14w ago
Liquid Biopsy Firm Freenome Finds a Way to the Public Markets via $330M SPAC Merger - MedCity News
Source: MedCity News
News
·
14w ago




